ANTI-ASTHMA OTC SWITCHES: COMMENTS REQUESTED ON TREATMENT AND PROPHYLAXIS
This article was originally published in The Tan Sheet
Executive Summary
ANTI-ASTHMA OTC SWITCHES: COMMENTS REQUESTED ON TREATMENT AND PROPHYLAXIS prescription regimens that may have potential for over-the-counter availability in an FDA "background document" published in the July 7 Federal Register. The document, which outlines the issues that will be discussed at a joint Nov. 14 meeting of the Nonprescription Drugs and Pulmonary-Allergy Drugs Advisory Committees, asks that interested parties should comment on the potential OTC availability of drugs both for treatment and prophylaxis of asthma.